Although its functional mechanism and expression patterns during oral carcinogenesis are not well defined, research characterizes BCL3 as a fugitive oncogene that affects a variety of epithelial and haematological malignancies [5]. The idea that elevated BCL3 expression creates an environment where tumours lessen immune cell responses to cancers is supported by scientific data. The gene discussed is BCL3; the disease is cancer.